$265.12 $0.35 (0.1%)

08:00 PM EDT on 07/02/20

Biogen Inc (NASDAQ:BIIB)

CAPS Rating: 4 out of 5

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.

Current Price $265.12 Mkt Cap $43.3B
Open $0.00 P/E Ratio 8.17
Prev. Close $265.12 Div. (Yield) $0.00 (0.0%)
Daily Range $0.00 - $0.00 Volume 943,015
52-Wk Range $215.78 - $374.99 Avg. Daily Vol. 1,690,341

Caps

How do you think NASDAQ:BIIB will perform against the market?

Add Stock to CAPS Watchlist

All Players

985 Outperform
73 Underperform
 

All-Star Players

219 Outperform
14 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:BIIB Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

sojournerks (97.45)
Submitted October 27, 2018

Good company in promising sector

JorgeAura (26.40)
Submitted February 02, 2013

Nasdaq in maximums.

Recent Community Commentary

Read the most recent pitches from players about BIIB.

Recs

0
Member Avatar tiomiguel (40.46) Submitted: 5/20/2020 5:07:37 PM : Outperform Start Price: $311.58 NASDAQ:BIIB Score: -20.05

Solid earnings and free-cash growth; well-positioned in auto-immune pharmaceuticals.

Recs

0
Member Avatar inov8d (46.23) Submitted: 3/16/2020 11:51:58 AM : Outperform Start Price: $300.22 NASDAQ:BIIB Score: -35.71

High profits, forward p/e of 9.93, bio stocks will do well during corona virus fears, up during crash today. Buy.

Recs

0
Member Avatar TMFAdriaCimino (55.60) Submitted: 2/20/2020 4:24:21 AM : Outperform Start Price: $338.00 NASDAQ:BIIB Score: -13.87

Though Biogen will face price fluctuations in the near term as investors wait to see if aducanumab for Alzheimer's is approved, in the long-term, Biogen's pipeline and products make it a solid investment.

Leaderboard

Find the members with the highest scoring picks in BIIB.

Score Leader

optioncoach

optioncoach (95.71) Score: +637.71

The Score Leader is the player with the highest score across all their picks in BIIB.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
fwhittlesey 23.80 4/12/2007 Outperform 3Y $43.64 +507.52% +129.34% +378.18 1 Comment
anewday101 90.90 3/5/2007 Outperform 1Y $43.36 +511.44% +139.95% +371.49 0 Comment
tradersinsights 72.15 4/10/2007 Outperform 1Y $44.42 +496.85% +128.12% +368.73 1 Comment
ambina < 20 3/12/2007 Outperform NS $43.95 +503.23% +134.98% +368.25 0 Comment
mtung 42.79 3/8/2007 Outperform NS $44.10 +501.18% +135.49% +365.69 0 Comment
gliberty < 20 8/22/2006 Outperform 5Y $42.68 +521.18% +156.08% +365.10 1 Comment
apple1jam 75.02 3/6/2007 2/27/2008 Outperform NS $43.94 +503.37% +138.47% +364.90 0 Comment
owen1000 80.18 8/22/2006 Outperform 3Y $42.83 +519.01% +155.71% +363.29 0 Comment
mgroeber < 20 4/9/2007 Outperform NS $44.86 +490.99% +127.90% +363.09 0 Comment
nickysone 75.91 4/9/2007 Outperform 3Y $44.86 +490.99% +127.90% +363.09 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BIIB.